ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 31

Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Inflammation and Joint Damage in the TNF-Tg Mouse Model

Maria de la Luz Garcia-Hernandez1, Javier Rangel-Moreno2, Ananta Paine2, Benjamin D. Korman1, Nelson Huertas2 and Christopher T. Ritchlin1, 1Division of Allergy/Immunology and Rheumatology and Center for Musculoskeletal Research, School of Medicine and Dentistry, University of Rochester Medical School, Rochester, New York, USA, Rochester, NY, 2Division of Allergy, Immunology and Rheumatology and Center for Musculoskeletal Research School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA, Rochester, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Pathologic bone resorption in rheumatoid arthritis (RA) is mediated by multinucleated osteoclasts (OC) at the bone-pannus junction. OC differentiation (OCgenesis) is dependent on a number of signals that promote cell fusion, formation of specific organelles and the development of a ruffled border. Dendritic Cell-Specific Transmembrane Protein (DC-STAMP), is upregulated in monocytes at early stages of OCgenesis and is required for cell-cell fusion. DC-STAMP-/-mice develop mild osteopetrosis, due to the presence of mononuclear OC with limited capacity to resorb bone. The role of DC-STAMP in the induction of joint inflammation and pathologic bone resorption has not been examined. Therefore, we determine whether the absence of DC-STAMP ameliorates joint inflammation and bone damage in the TNF transgenic murine arthritis model.

Methods: Four experimental groups of 7-month old C57BL/6, DC-STAMP-/-, TNF-Tg and DC-STAMP-/- x TNF-Tg mice were generated. The presence of arthritis was determined by visual examination along with recording of grip strength, and ankle width. We analyzed the impact of DCSTAMP deficiency on bone architecture with mCT-scan analysis. The extent of tibial bone resorption was determined by the area occupied by OC in bone sections. Serum cytokines were quantitated by multiplex assay and the accumulation of inflammatory cells in bone sections was quantitated by immunofluorescence microscopy.

Results: DC-STAMP-/-x TNF-Tg mice had a 2.5-fold decrease in ankle thickness from week 28 to 49 of age, compared to age-matched TNF-Tg mice (p<0.0001), and was comparable to that of C57BL/6 and DC-STAMP-/- mice. Notably, DC-STAMP-/- x TNF Tg mice had a significantly smaller TRAP+area in the tibia, compared to the TRAP+ area in the tibia of TNF-Tg mice (1.05 ±0.1 vs 17.3 ±0.6, p=0.0001). Consistent with the reduction in OC in the tibia, we found a four-fold reduction in bone resorption by OCs in DCSTAMP-/- x TNF-Tg mice, compared to TNF-Tg mice (0.053 ±0.05 vs. 0.21 ±0.005, p=0.002). Accumulation of inflammatory cells in the synovia and systemic levels of proinflammatory molecules were markedly reduced in DC-STAMP-/- x TNF-Tg mice (IL-α: 80 pg/ml, 3-fold decrease, p=0.001; TNF-α: 20 pg/ml, 30-fold decrease, p=0.04 and MCP1: 56 pg/ml, 3-fold decrease, p=0.04). In contrast, macrophage infiltration was abundant in the synovial tissue from TNF-Tg mice and correlated with the significantly higher levels of MCP1 (170 pg/ml), a chemokine that attracts macrophages into inflamed tissues.

Conclusion: In addition to the well-known role of DC-STAMP in cell-cell fusion, we found that it is required for progressive development of synovitis and joint damage in the setting of TNF mediated arthritis. Apparently, DC-STAMP modulates synovitis and joint damage through regulation of signaling events that promote differentiation and activation of monocytes and possibly other immune cells.


Disclosure: M. D. L. L. Garcia-Hernandez, None; J. Rangel-Moreno, None; A. Paine, None; B. D. Korman, None; N. Huertas, None; C. T. Ritchlin, AbbVie, Amgen, UCB, 2,AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer Inc, 5.

To cite this abstract in AMA style:

Garcia-Hernandez MDLL, Rangel-Moreno J, Paine A, Korman BD, Huertas N, Ritchlin CT. Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Inflammation and Joint Damage in the TNF-Tg Mouse Model [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/dendritic-cell-specific-transmembrane-protein-dc-stamp-regulates-inflammation-and-joint-damage-in-the-tnf-tg-mouse-model/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dendritic-cell-specific-transmembrane-protein-dc-stamp-regulates-inflammation-and-joint-damage-in-the-tnf-tg-mouse-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology